Manufacturing, Cell-Line Selection

New Protein Production Platform

August 01, 2024

Syngene’s protein production platform uses a cell line and transposon-based technology licensed from Switzerland-based ExcellGene.

Mapp Biopharmaceutical Teams Up with ProBioGen and to Develop Antibody Against Marburg Virus Disease

March 16, 2024

Mapp Biopharmaceutical will use ProBioGen’s GlymaxX technology for the development of an afucosylated antibody against Marburg virus infection

Abzena Launches New Cell Line Development Platforms

January 22, 2024

Abzena has launched its AbZelect platforms, designed for improving cell line development.

Lonza Launches New Cell Line for Higher Potency Antibody Development

November 16, 2023

Lonza’s new GS Effex cell line can help overcome the challenges of developing therapeutic antibodies with increased potency.

Cytiva Acquires CEVEC, Boosts Cell Line Development Capabilities

October 10, 2022

Cytiva’s acquisition of CEVEC Pharmaceuticals strengthens the company’s cell line development and biomanufacturing capabilities.

Thermo Fisher Scientific Launches Large-Scale Cell Culture Harvesting Solution

October 07, 2022

Thermo Fisher’s new centrifuge technology is designed to enable efficient, sustainable cell culture harvesting.

Catalent Biologics Launches New Cell Line Expression Technology

July 22, 2021

Catalent Biologics has launched its new cell line expression technology, GPEx Lightning, which aims to shorten drug substance development timelines by up to three months.

New Biotherapies Push Technological Innovation Forward

June 03, 2021

The emergence of new biotherapeutics is both the driver and result of innovative drug development technologies.

Berkeley Lights Launches Assay Series for Early Cell-Line Development Yield and Product Quality

April 06, 2021

The company has introduced Opto Assure, a series of assays that provide yield and product quality data at an earlier stage in cell-line development.

Samsung Biologics Incorporates Solentim’s Cell Line Development Technology into New R&D Center

November 05, 2020

Samsung Biologics has adopted Solentim’s cell seeding and cell metric platforms at its new R&D center in San Francisco, CA.